Condensed Interim Statements of Cash Flows (USD $)	3 Months Ended	8 Months Ended
	Mar. 31, 2014	Mar. 31, 2014
Cash flows from operating activities:
Net loss attributable to common shares	$ (243,158)	$ (362,549)
Changes in operating assets and liabilities
Accrued interest income	(12,124)	(47,787)
Accrued expenses	45,006	90,702
Prepaid insurance	25,371	(135,312)
Prepaid expenses	(16,755)	(24,663)
Franchise tax payable	19,552	45,000
Net cash used in operating activities	(182,108)	(434,609)
Cash flows from investing activities:
Principal deposited in Trust Account	0	(150,000,000)
Cash flow from financing activities:
Proceeds from sale of common stock to Sponsor	0	25,000
Net proceeds from Public Offering, after payment of upfront underwriting fee	0	147,000,000
Net proceeds from private placement warrants	0	4,750,000
Payment of offering expenses	0	(444,033)
Net cash provided by financing activities	0	151,330,967
Net increase (decrease) in cash	(182,108)	896,358
Cash at beginning of the period	1,078,466	0
Cash at end of the period	896,358	896,358
Supplemental disclosure of non-cash financing activities:
Deferred underwriting commissions	$ 0	$ 5,250,000